FEV
Basic information
Region (hg38): 2:218981087-218985184
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FEV gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 14 | 14 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 14 | 0 | 2 |
Variants in FEV
This is a list of pathogenic ClinVar variants found in the FEV region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-218981681-C-T | not specified | Uncertain significance (Oct 06, 2024) | ||
2-218981687-A-C | not specified | Uncertain significance (Feb 28, 2023) | ||
2-218981747-G-C | not specified | Uncertain significance (Mar 11, 2024) | ||
2-218981768-C-G | not specified | Uncertain significance (Apr 01, 2024) | ||
2-218981774-C-G | not specified | Uncertain significance (Aug 02, 2021) | ||
2-218981797-G-A | not specified | Uncertain significance (Jul 15, 2021) | ||
2-218981842-A-G | not specified | Uncertain significance (Jun 07, 2024) | ||
2-218981866-G-A | not specified | Uncertain significance (Mar 04, 2024) | ||
2-218981890-G-T | not specified | Uncertain significance (May 14, 2024) | ||
2-218981891-C-T | not specified | Uncertain significance (May 14, 2024) | ||
2-218981905-A-G | not specified | Uncertain significance (Mar 13, 2023) | ||
2-218981908-G-A | not specified | Uncertain significance (Feb 27, 2024) | ||
2-218981957-G-A | not specified | Uncertain significance (Dec 10, 2024) | ||
2-218981970-C-A | Benign (Jun 29, 2018) | |||
2-218981971-G-T | not specified | Uncertain significance (Jul 19, 2022) | ||
2-218982031-T-G | not specified | Uncertain significance (Oct 20, 2024) | ||
2-218982039-G-C | not specified | Uncertain significance (Apr 17, 2024) | ||
2-218982049-T-C | not specified | Uncertain significance (Aug 30, 2022) | ||
2-218982127-C-T | not specified | Uncertain significance (Nov 11, 2024) | ||
2-218982130-C-T | not specified | Uncertain significance (Dec 03, 2021) | ||
2-218982446-C-CT | Benign (Apr 19, 2019) | |||
2-218984237-G-T | not specified | Uncertain significance (Dec 03, 2021) | ||
2-218984261-A-G | not specified | Uncertain significance (Mar 29, 2023) | ||
2-218984266-G-C | not specified | Uncertain significance (Jul 12, 2022) | ||
2-218984268-G-T | not specified | Uncertain significance (Mar 19, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FEV | protein_coding | protein_coding | ENST00000295727 | 3 | 4571 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00811 | 0.803 | 125323 | 0 | 3 | 125326 | 0.0000120 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.43 | 52 | 90.1 | 0.577 | 0.00000403 | 1492 |
Missense in Polyphen | 26 | 46.805 | 0.5555 | 568 | ||
Synonymous | 0.908 | 34 | 41.4 | 0.820 | 0.00000196 | 496 |
Loss of Function | 1.02 | 4 | 6.90 | 0.580 | 2.97e-7 | 86 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000113 | 0.00000884 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.000164 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Functions as a transcriptional regulator. According to PubMed:12761502, it functions as a transcriptional repressor. Functions in the differentiation and the maintenance of the central serotonergic neurons. May play a role in cell growth. {ECO:0000269|PubMed:12761502}.;
- Disease
- DISEASE: Note=A chromosomal aberration involving FEV is found in Ewing tumors. Translocation t(2;21;22)(q23;q22;q12) that forms a EWSR1-FEV fusion protein with a potential oncogenic activity. {ECO:0000269|PubMed:9121764}.;
- Pathway
- Transcriptional misregulation in cancer - Homo sapiens (human);Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways
(Consensus)
Recessive Scores
- pRec
- 0.192
Haploinsufficiency Scores
- pHI
- 0.195
- hipred
- hipred_score
- ghis
- 0.482
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.801
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Fev
- Phenotype
- cellular phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Zebrafish Information Network
- Gene name
- fev
- Affected structure
- ventral wall of dorsal aorta
- Phenotype tag
- abnormal
- Phenotype quality
- decreased process quality
Gene ontology
- Biological process
- regulation of transcription by RNA polymerase II;transcription by RNA polymerase II;positive regulation of gene expression;cell differentiation;neuron maturation;neuron fate specification;negative regulation of nucleic acid-templated transcription
- Cellular component
- nucleus;nuclear speck
- Molecular function
- DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription factor activity;transcription corepressor activity;sequence-specific DNA binding